Regulation of anabolic steroids will be in effect Jan. 1, 2009, in Ohio.
The Ohio State Racing Commission, at its Sept. 17 meeting, unanimously adopted regulations and forwarded them to the analytical toxicology laboratory at the Ohio Department of Agriculture. Officials said the policy ensures that the racing commission will be in compliance with the model rule on steroids.
The Ohio rule, like the model rule devised by the Association of Racing Commissioners International and Racing Medication and Testing Consortium, covers four commonly used steroids: boldenone, nandrolone, stanozolol, and testosterone.
The lab has been instructed to notify the racing commission of the following:
--any urine that tests positive for 16b-hydroxystanozolol (a metabolite of stanozolol) at a concentration greater than one nanogram per milliliter of urine for all racehorses regardless of sex;
--any urine that tests positive for boldenone at a concentration greater than 15 ng/ml of urine in male horses other than geldings, and any amount in geldings or females;
--any urine that tests positive for nandrolone at a concentration greater than one ng/ml of urine in geldings and females, and any urine that tests positive for 5a-Estrane-3b, 17a-diol (a metabolite of nandrolone) at a concentration greater than 45 ng/ml of urine in male horses other than geldings;
--any urine that tests positive for testosterone at a concentration greater than 20 ng/ml of urine in geldings, and greater than 55 ng/ml in females.
The OSRC said the lab will not report urine that tests positive for testosterone if it comes from male horses other than a gelding. The lab will report any urine sample that shows the presence of more than one of the four androgenic anabolic steroids at concentrations greater than the individual threshold levels.